Envoy Medical COCH 深 沪
等待开盘 09-02 09:30:00 美东时间
0.7044
-0.025
-3.37%
华盛通- 最 高0.729
- 今 开0.729
- 成交量 2.67万股
- 最 低 0.7006
- 昨 收 0.729
- 总市值 5437.59万
- 52周最高 1.89
- 市盈率 静 --
- 换手率 0.03%
- 52周最低 0.3625
- 委 比 -33.33%
- 总股本 7719.46万
- 历史最高 11.72
- 量 比 0.59
- 振 幅 3.90%
- 历史最低 0.00
- 每 手 1
- 风险率 0.17%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 罗斯百货、迪尔股份获多家大行上调目标价；沃尔玛、Advance遭多家大行下调目标价
今日重点评级关注：摩根士丹利：维持Ultragenyx Pharmaceutical"超配"评级，目标价从67美元升至74美元；Truist Securities：维持Solid Biosciences"买入"评级，目标价从16美元升至20美元
08-24 16:40
Ross Stores To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Friday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Baird raised the price target for Parsons Corp (NYSE:PSN) from $48 to $57. Baird analyst Andrew Wittmann upgra...
08-21 20:24
HC Wainwright & Co. Maintains Buy on Envoy Medical, Lowers Price Target to $2
HC Wainwright & Co. analyst Yi Chen maintains Envoy Medical (NASDAQ:COCH) with a Buy and lowers the price target from $2.5 to $2.
08-21 18:27
Envoy Medical Q2 EPS $(0.07) Beats $(0.08) Estimate, Sales $51.000K Miss $80.000K Estimate
Envoy Medical (NASDAQ:COCH) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.08) by 12.5 percent. This is a 78.13 percent increase over losses of $(0.32) per share from the same period last year. The company reported quarterly sales of $51.000 thousand ...
08-10 20:15
美股大行评级 | ITG、Bending Spoons获多家大行首予买入评级；瑞银下调微软目标价从510美元降至480美元
今日重点评级关注：BTIG：上调Outlook Therapeutics"买入"评级，目标价4美元；TD Cowen：维持Nakamoto"买入"评级，目标价从1美元升至17美元
07-28 11:34
LUCID CAPITAL MARKETS Initiates Coverage On Envoy Medical with Buy Rating, Announces Price Target of $2
LUCID CAPITAL MARKETS analyst Alex Nowark initiates coverage on Envoy Medical (NASDAQ:COCH) with a Buy rating and announces Price Target of $2.
07-27 20:07
美股大行评级 | 潜在涨幅284.62%！Annexon获Needham上调目标价至25美元；多家大行上调美国银行目标价
今日重点评级关注：Needham：维持Annexon"买入"评级，目标价从11美元升至25美元；Benchmark：维持Prenetics Global"买入"评级，目标价从30美元升至40美元
07-16 18:55
HC Wainwright & Co. Reiterates Buy on Envoy Medical, Maintains $2.5 Price Target
HC Wainwright & Co. analyst Yi Chen reiterates Envoy Medical (NASDAQ:COCH) with a Buy and maintains $2.5 price target.
07-15 19:45
EXCLUSIVE: Envoy Medical Builds Momentum With Improved Cochlear Implant Trial Results
Envoy Medical Inc. (NASDAQ:COCH) on Tuesday reported 12-month results from the first 10 participants in Stage 1 of its pivotal clinical trial evaluating the investigational fully implanted Acclaim cochlear implant, with hearing performance continuing to improve over previously reported six-month dat...
07-14 21:01
Envoy Medical Terminates At-The-Market Equity Facility To Offer, Sell $15M Common Shares
Envoy Medical®, Inc. (NASDAQ:COCH) ("Envoy Medical"), a hearing health company pioneering fully implanted hearing solutions, today announced that it has formally terminated its at-the-market equity facility (the "ATM Facility"). The ATM Facility, under which the Company was previously authorized to ...
06-25 20:40
